HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yongkun Sun Selected Research

Stomach Neoplasms (Stomach Cancer)

3/2022Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study.
6/2020Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective study.
5/2018Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer.
9/2017Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection.
3/2017Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
6/2015S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial.
6/2015Phase I dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unresectable locally advanced or metastatic gastric cancer.
5/2014[Detection and significance of epidermal growth factor receptor mutation in esophageal, esophagogastric junction and gastric cancers].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yongkun Sun Research Topics

Disease

14Neoplasms (Cancer)
03/2022 - 05/2014
8Stomach Neoplasms (Stomach Cancer)
03/2022 - 05/2014
4Hypertension (High Blood Pressure)
05/2022 - 10/2016
4Disease Progression
09/2021 - 06/2015
3Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 06/2019
3Adenocarcinoma
10/2018 - 06/2015
2Biliary Tract Neoplasms (Biliary Tract Cancer)
05/2022 - 01/2021
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2021
2Neoplasm Metastasis (Metastasis)
10/2021 - 06/2020
2Colonic Neoplasms (Colon Cancer)
01/2021 - 10/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 10/2016
2Proteinuria
01/2020 - 11/2018
2Sarcoma (Soft Tissue Sarcoma)
11/2018 - 10/2016
2Renal Cell Carcinoma (Grawitz Tumor)
06/2016 - 01/2016
2Fetal Nutrition Disorders (Fetal Malnutrition)
09/2013 - 01/2013
1Esophageal Squamous Cell Carcinoma
01/2022
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2021
1Inflammation (Inflammations)
01/2019
1Lymphoma (Lymphomas)
01/2019
1Hand-Foot Syndrome
11/2018
1Fatigue
11/2018
1medullary Thyroid cancer
11/2018
1Pneumothorax
11/2018
1Hypertriglyceridemia
11/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2018
1Thyroid Neoplasms (Thyroid Cancer)
10/2016
1Hyperlipidemias (Hyperlipidemia)
06/2016
1Hypercalcemia (Milk Alkali Syndrome)
01/2016
1Anemia
01/2016
1Body Weight (Weight, Body)
01/2013

Drug/Important Bio-Agent (IBA)

8anlotinibIBA
05/2022 - 10/2016
5Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2022 - 06/2015
4Tyrosine Kinase InhibitorsIBA
05/2022 - 05/2014
3Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2020
3Phosphotransferases (Kinase)IBA
09/2021 - 01/2019
3Triglycerides (Triacylglycerol)IBA
11/2018 - 01/2013
2tyrosine receptor (receptor, tyrosine)IBA
09/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2014
2LipidsIBA
06/2016 - 01/2013
2ErbB Receptors (EGF Receptor)IBA
06/2015 - 05/2014
1B7-H1 AntigenIBA
05/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2022
1Alanine Transaminase (SGPT)IBA
05/2022
1sintilimabIBA
01/2022
1Biosimilar PharmaceuticalsIBA
01/2022
1Bevacizumab (Avastin)FDA Link
01/2022
1Deubiquitinating EnzymesIBA
01/2022
1RNA Splicing FactorsIBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021
1CytokinesIBA
06/2021
1HMPL-013IBA
01/2021
1XELOXIBA
06/2020
1Capecitabine (Xeloda)FDA Link
06/2020
1Pharmaceutical PreparationsIBA
01/2020
1dimethylarginineIBA
01/2020
1N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)IBA
01/2020
1chiauranibIBA
01/2019
1Aurora Kinase BIBA
01/2019
1Angiogenesis InhibitorsIBA
11/2018
1CholesterolIBA
11/2018
1130-nm albumin-bound paclitaxelIBA
10/2018
1Lipase (Acid Lipase)FDA Link
10/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2016
1lactate dehydrogenase 1 (LDH1)IBA
01/2016
1Cisplatin (Platino)FDA LinkGeneric
06/2015
1Fluorouracil (Carac)FDA LinkGeneric
06/2015
1Leucovorin (Folinic Acid)FDA Link
06/2015
1Sorafenib (BAY 43-9006)FDA Link
06/2015
1nimotuzumabIBA
06/2015
1TeaIBA
09/2013
1PolyphenolsIBA
01/2013
1Adenosine Monophosphate (AMP)IBA
01/2013
1Protein Kinases (Protein Kinase)IBA
01/2013
1Sterol Regulatory Element Binding Protein 1IBA
01/2013

Therapy/Procedure

6Therapeutics
03/2022 - 10/2018
6Drug Therapy (Chemotherapy)
03/2022 - 06/2015
2Adjuvant Chemotherapy
01/2021 - 05/2018
2Neoadjuvant Therapy
09/2017 - 03/2017
1Oral Administration
09/2021
1Immunotherapy
09/2021
1Gastrectomy
06/2020
1Combination Drug Therapy (Combination Chemotherapy)
06/2015